Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit B10 pseudogene 2 (NDUFB10P2)

Target
NDUFB10P2
Molecular classification
Other (Pseudogene)
01

Overview

NADH:ubiquinone oxidoreductase subunit B10 pseudogene 2 (NDUFB10P2) is a pseudogene annotated in several genomic databases. Pseudogenes are segments of DNA resembling known genes but rendered nonfunctional by mutations; they typically do not encode active protein products. However, emerging research shows that some pseudogenes can be transcribed into RNA and may play a regulatory role, such as modulating expression of their parent gene through mechanisms like competing endogenous RNAs (ceRNAs) or serving as microRNA decoys. Despite this, there is currently no evidence that NDUFB10P2 itself acts as a functional regulator or is directly involved in human disease, nor is it targeted by any therapeutics. Key points: - This entry is a pseudogene, not a protein, receptor, or enzyme. - It is not considered a canonical drug target. - Any functional effects would be indirect and hypothetical, reflecting general features of pseudogenes rather than something known for NDUFB10P2 itself.

Other names
NDUFB10 pseudogene 2NDUFB10P2
02

Biological functions

Regulation of gene expression (indirectly, through non-coding RNA mechanisms typical of pseudogenes)
03

Disease associations

Other (Some pseudogenes have been implicated in cancer and gene regulation by acting as microRNA decoys or interfering RNAs, but there is no direct evidence for NDUFB10P2 specifically)

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit B10 pseudogene 2 (NDUFB10P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B10 pseudogene 2 (NDUFB10P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call